Suppr超能文献

用于功能性胃肠疾病的药用食品。

Medicinal Foods for Functional GI Disorders.

作者信息

Acker Brent W, Cash Brooks D

机构信息

Department of Medicine, Division of Gastroenterology, University of South Alabama School of Medicine, 6000 University Commons, 75 University Blvd., South, Mobile, AL, 36688, USA.

出版信息

Curr Gastroenterol Rep. 2017 Nov 13;19(12):62. doi: 10.1007/s11894-017-0601-x.

Abstract

PURPOSE OF REVIEW

Over the past 10 years, there has been a dramatic increase in basic and clinical research involving functional gastrointestinal disorders (FGIDs). New diagnostic and biomarker procedures are helping to identify physiologic disruptions associated with FGIDs on cellular and molecular levels. Simultaneously, clinicians are using new approaches to help manage patients with FGIDs. Among these, an important component of care has been the use of medical foods. These include probiotics, prebiotics, synbiotics, peppermint oil, caraway oil, curcumin, bovine immunoglobulin and many others.

RECENT FINDINGS

The putative effects of different medical foods make these therapies attractive for the management of FGIDs. These include effects on several pathophysiological mechanisms such as anti-inflammatory, smooth muscle relaxation, analgesia, mitigation of gut barrier dysfunction, and stimulation or inhibition of gastrointestinal receptors. Recent research has also demonstrated the efficacy of medical food products such as peppermint oil and serum-derived bovine immunoglobulin for the management of irritable bowel syndrome. Older data supports the probiotic VSL#3 and Bifidobacterium species. For functional dyspepsia, positive effects have been observed with the combination of caraway seed oil and peppermint oil as well as with STW-5, a botanical combination preparation, although robust RCTs are lacking. With advancing knowledge regarding the pathogenesis of FGIDs, it is likely that the compounds available in the medical food category will increase dramatically, and they could play an important role in the management of several common and bothersome gastrointestinal conditions in the future.

摘要

综述目的

在过去10年中,涉及功能性胃肠疾病(FGIDs)的基础和临床研究急剧增加。新的诊断和生物标志物检测方法有助于在细胞和分子水平上识别与FGIDs相关的生理紊乱。同时,临床医生正在采用新方法来帮助管理FGIDs患者。其中,医疗食品的使用是护理的一个重要组成部分。这些包括益生菌、益生元、合生元、薄荷油、葛缕子油、姜黄素、牛免疫球蛋白等许多物质。

最新发现

不同医疗食品的假定作用使这些疗法对FGIDs的管理具有吸引力。这些作用包括对多种病理生理机制的影响,如抗炎、平滑肌松弛、镇痛、减轻肠道屏障功能障碍以及刺激或抑制胃肠道受体。最近的研究还证明了薄荷油和血清源性牛免疫球蛋白等医疗食品对肠易激综合征的治疗效果。较早的数据支持益生菌VSL#3和双歧杆菌属。对于功能性消化不良,虽然缺乏有力的随机对照试验,但已观察到葛缕子籽油和薄荷油的组合以及植物组合制剂STW-5具有积极作用。随着对FGIDs发病机制的认识不断深入,医疗食品类别中的可用化合物可能会大幅增加,它们未来可能在几种常见且令人困扰的胃肠道疾病的管理中发挥重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验